Article
New genetic variants associated with major adverse cardiovascular events in patients with acute coronary syndromes and treated with clopidogrel and aspirin.
The pharmacogenomics journal - 1 Dec 2021
Liu Xiaomin, Xu Hanshi, Xu Huaiqian, Geng Qingshan, Mak Wai-Ho, Ling Fei, Su Zheng, Yang Fang, Zhang Tao, Chen Jiyan, Yang Huanming, Wang Jian, Zhang Xiuqing, Xu Xun, Jia Huijue, Zhang Zhiwei, Liu Xiao, Zhong Shilong
Abstract excerpt
Although a few studies have reported the effects of several polymorphisms on major adverse cardiovascular events (MACE) in patients with acute coronary syndromes (ACS) and those undergoing percutaneous coronary intervention (PCI), these genotypes account for only a small fraction of the variation and evidence is insufficient. This study aims to identify new genetic variants associated with MACE end point during...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.